Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin a… Ended

2022-502605-15-00 Participants with transthyretin amyloid cardiomyopathy 4 2024-09-16
An exploratory, randomized, double-blind, multicentre, placebo-controlled study of RTP-026 to assess safety, tolerability, and efficacy in p… Ended

2023-509182-21-00 Patients with ST-Elevation Myocardial Infarction (STEMI 4 2024-09-16
Pilot study for the evaluation of [68Ga]Ga-PentixaFor PET imaging for the identification of unilateral adrenal secretion of ALdosterON in pa… Ended

2023-505507-22-00 Primary aldosteronism 10 2024-09-12
BOTAF - Prevention of post-operative Atrial Fibrillation by BOTulinum toxin injections into epicardial fat pads around pulmonary veins in pa… Ended

2024-513645-37-00 Adult patients with indication for conventional cardiac 5 2024-09-05
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
A Study of Mavacamten in Adolescent Participants with Symptomatic Obstructive Hypertrophic Cardiomyopathy Ended

2023-505650-17-00 Symptomatic Obstructive Hypertrophic Cardiomyopathy 5 2024-08-27
MLS-101-901: An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundrostat in Subjects with Hyper… Ended

2023-508670-28-00 Hypertension 5 2024-08-26
Extension trial for adults with high cholesterol who completed a MK-0616 clinical trial Ended

2023-504922-20-00 Hypercholesterolemia 5 2024-08-23
Rivaroxaban Monotherapy and CYP2C19 Genotype Testing in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention Ended

2023-508904-39-00 Coronary artery disease 6 2024-08-22
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
DUTCH-WAIST Ended

2022-501392-81-00 Obesity 6 2024-07-25
Antioxidant Treatment with Vitamin C in Cardiac Surgery Patients - A Pilot Randomized Controlled Trial Ended

2023-510561-10-00 Cardiovascular illness, Intensive care unit (ICU), open 4 2024-07-19
An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arte… Ended

2023-506334-75-00 Pulmonary Arterial Hypertension 5 2024-07-12
Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis intervention Ended

2024-514868-11-00 Aortic stenosis 10 2024-07-04
A clinical trial to evaluate efficacy, safety and cost-efficacy of gene analysis strategy in a population at risk of cardiovascular disease … Ended

2023-509418-12-00 Patients at risk of cardiovascular disease susceptible 6 2024-06-05
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin alone and how safe it is in adults with chronic kidn… Ended

2023-506457-38-00 Chronic kidney disease (CKD) and hypertension. 5 2024-06-05
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Ended

2022-502781-24-01 ASCVD - Atherosclerotic Cardiovascular Disease 5 2024-06-05
Multicenter, randomized, double-blind, Phase III study of intravenous TAD® 600 mg/4 ml solution for injection to evaluate efficacy and safet… Ended

2023-503950-11-00 Myocardial injury in patients affected by pneumonia 5 2024-05-07
A study to determine if ALXN2220 is effective, safe, and tolerable in adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Ended

2023-506669-70-00 Adults with Transthyretin Amyloid Cardiomyopathy (ATTR- 5 2024-04-30
ATHENA: A research study looking into how ziltivekimab works compared to placebo in people with heart failure and inflammation Ended

2023-506988-34-00 Heart failure with mildly reduced or preserved ejection 5 2024-03-27
MAGNETICAL - MAGNetic resonance Evaluation of Tafamidis Impact in Cardiac AmyLoidosis Ended

2024-518708-29-00 Transthyretin cardiac amyloidosis 6 2024-03-13
Phase 1/2, Open label & double-blind randomized placebo-controlled study to assess the feasibility of BGC101 (EnEPC) in the treatment of per… Ended

2024-516665-36-00 Peripherial arterial disease (PAD) & Chronic-Limb Threa 7 2024-01-23
Aspirin to prevent cardiovascular events in patients with pneumonia or influenza Ended

2023-504553-12-01 Influenza 6 2023-12-27
Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib in G12C NSCLC Patients (RAMP203) Ended

2023-505107-24-00 Non-small cell lung cancer 9 2023-11-14